Ashraf M. Muhammad

Dr. Ashraf M. Muhammad

Ain Shams University, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Ashraf M. MuhammadAshraf M. Muhammad
Ashraf M. Muhammad
AZAli Talal Zari
Ali Talal Zari
NANouf H. Alsubhi
Nouf H. Alsubhi
MAMaryam Hassan Al-Zahrani
Maryam Hassan Al-Zahrani
RARana Alghamdi
Rana Alghamdi
Mai LabibMai Labib
Mai Labib
Aptamers, the nucleic acid analogs of antibodies, bind to their target molecules with remarkable specificity and sensitivity, making them promising diagnostic and therapeutic tools. The systematic evolution of ligands by exponential enrichment (SELEX) is time-consuming and expensive. However, regardless of those issues, it is the most used in vitro method for selecting aptamers. Therefore, recent studies have used computational approaches to reduce the time and cost associated with the synthesis and selection of aptamers. In an effort to present the potential of computational techniques in aptamer selection, a simple sequence-based method was used to design a 69-nucleotide long aptamer (mod_09) with a relatively stable structure (with a minimum free energy of −32.2 kcal/mol) and investigate its binding properties to the tyrosine kinase domain of the NT-3 growth factor receptor, for the first time, by employing computational modeling and docking tools.